Protection by bone marrow grafts against lethal doses of 5-fluorouracil
- 1 November 1984
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 20 (11) , 1441-1444
- https://doi.org/10.1016/0277-5379(84)90065-8
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Allogeneic Bone‐Marrow TransplantationImmunological Reviews, 1983
- MARROW TRANSPLANTATION FOR THALASSAEMIAThe Lancet, 1982
- Treatment of Chronic Granulocytic Leukemia with Chemoradiotherapy and Transplantation of Marrow from Identical TwinsNew England Journal of Medicine, 1982
- Control of a human tumour (ewing sarcoma) in mice by a single lethal dose of dimethyl-myleran and bone marrowInternational Journal of Cancer, 1981
- Dose: A critical factor in cancer chemotherapyThe American Journal of Medicine, 1980
- THE PLACE OF BONE-MARROW TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKÆMIAThe Lancet, 1980
- Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high-dose melphalanBritish Journal of Cancer, 1979
- Bone-marrow Transplantation after Antilymphocytic Serum and Lethal ChemotherapyNature, 1969
- System for the Recognition of Genetic Transformation in Hæmopoietic CellsNature, 1962
- Protection of August Rats Against Lethal Doses of a Dimethyl Homologue of Myleran by Isologous Bone MarrowNature, 1958